Europe Nuclear Medicine Diagnostics Market By SPECT (Technetium-99m, Iodine, Thallium-201 And Others) And PET (Rubidium-82, Fluorine-18, And Others)), By Application (cardiology, Lymphoma, Thyroid, Neurology, Oncology) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)
Europe Nuclear Medicine Diagnostics Market By SPECT (Technetium-99m, Iodine, Thallium-201 And Others) And PET (Rubidium-82, Fluorine-18, And Others)), By Application (cardiology, Lymphoma, Thyroid, Neurology, Oncology) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)
ID: 125 | Pages: 141 | April 2018 | Region: Europe
Overview of the Market:
The Europe nuclear medicine diagnostic market is estimated at $3.03 billion in 2018 and is expected to reach $5.24 billion by 2023, at a compound annual growth rate (CAGR) of 11.60%.Nuclear medicine is a branch of medicine that uses radiation to deliver information about the functioning of a person's specific organs or to treat a disease. In most cases, the information will assist the physicians to make a quick, accurate diagnosis of the patient's illness.
Till today, SPECT imaging was the most conventional modality for nuclear medicine applications such as nuclear cardiology procedures. However, the trend is soon going to see a down turn owing to shortage of molybdenum-99 isotope which is in turn will lead to deficiency of Technetium-99, which is the by-product of molybdenum. Therefore, PET imaging products which include hybrid PET-CT scanners is expected to account for a potentially hefty market size in the near future.
The emerging market will be a fusion of nuclear imaging with different diagnostic imaging products such as SPECT/CT, PET/CT and MRI/PET. This provides full range of imaging scans through the same unit and at the same time. PET market is expected to witness faster growth compared to SPECT imaging as it delivers higher resolution images. Lack of availability of technetium-99m is also forcing the industry to look for alternative diagnostic procedures
Increasing usage of SPECT and PET in medical diagnostics, rising awareness among people about radiopharmaceuticals, and ready availability of radiopharmaceuticals are some of the major factors driving the growth of the market. However, shorter half- life of radioisotopes, regulatory guidelines, high capital investment and reimbursement issues are the key factors restraining the market growth.
The Nuclear Medicine Market is segmented into two major segments SPECT (Technetium-99m (TC-99m), Iodine (I-123) Thallium-201 (TL-201) and others) and PET (Rubidium-82 (RB-82), Fluorine-18, and others). By application,the market is categorized into SPECT (lymphoma, cardiology,neurology,thyroid and others) and PET(cardiology,oncology, neurology and others).
Geographical Analysis:
Furthermore, on the basis of geography, the European Market is analysed under various regions namely, UK, Spain, Italy, Germany and France.
Key Players in this Market:
Some of the key players influencing the Europe nuclear medicine market are Cardinal Health, Inc., Bracco Imaging S.p.A,GE Healthcare,Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc.,Advanced Accelerator Applications S.A., IBA Molecular Imaging, and Mallinckrodt plc.
- Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
- Research Methodology
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
- Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
- Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
- Market Segmentation
5.1 By Type
5.1.1 SPECT
5.1.1.1 Technetium-99m
5.1.1.2 Thallium-201
5.1.1.3 Gallium-67
5.1.1.4 Iodine-23
5.1.1.5 Others
5.1.2 PET
5.1.2.1 Fluorine-18
5.1.2.2 Rubidium-82
5.1.2.3 Others
5.2 By Application
5.2.1 Cardiology
5.2.2 Lymphoma
5.2.3 Thyroid
5.2.4 Neurology
5.2.5 Oncology
5.2.6 Others
- Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
- Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
- Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Cardinal Health Inc.
8.3 Bracco Imaging S.p.A
8.4 Eczacibasi-Monrol Nuclear Products
8.5 Nordion, Inc.
8.6 Bayer Healthcare
8.7 Lantheus Medical Imaging, Inc.
8.8 Advanced Accelerator Applications S.A.
8.9 IBA Molecular Imaging
8.10 Mallinckrodt plc.
- Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
- Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
- List of Tables
- List of Figures
- Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
- Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
- Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
- Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
- Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
- A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
- Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
- An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
- Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
| Title | Price | Add To Cart |
- Europe Nuclear Medicine Diagnostics Market By Region, From 2018-2023 (USD Billion)
- Europe Nuclear Medicine Diagnostics Market By Type, From 2018-2023 (USD Billion)
- Europe SPECT Diagnostic Radioisotopes Market By Region, From 2018-2023 (USD Billion)
- Europe PET Diagnostic Radioisotopes Market By Region, From 2018-2023 (USD Billion)
- Europe Nuclear Medicine Diagnostics Market By Application, From 2018-2023 (USD Billion)
- Europe Cardiology Market By Region, From 2018-2023 (USD Billion)
- Europe Lymphoma Market By Region, From 2018-2023 (USD Billion)
- Europe Thyroid Market By Region, From 2018-2023 (USD Billion)
- Europe Neurology Market By Region, From 2018-2023 (USD Billion)
- Europe Oncology Market By Region, From 2018-2023 (USD Billion)
- Europe Other Applications Market By Region, From 2018-2023 (USD Billion)
- Europe SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
- Europe Technetium-99m Market By Region, From 2018-2023 ( USD Billion )
- Europe Thallium-201 Market By Region, From 2018-2023 ( USD Billion )
- Europe Gallium-67 Market By Region, From 2018-2023 ( USD Billion )
- Europe Iodine-23 Market By Region, From 2018-2023 ( USD Billion )
- Europe Other SPECT Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Billion )
- Europe PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
- Europe Fluorine-18 Market By Region, From 2018-2023 ( USD Billion )
- Europe Rubidium-82 Market By Region, From 2018-2023 ( USD Billion )
- Europe Other PET Diagnostic Radioisotopes Market By Region, From 2018-2023 ( USD Billion )
- U.K Nuclear Medicine Diagnostics Market By Type, From 2018-2023 (USD Billion)
- U.K Nuclear Medicine Diagnostics Market By Application, From 2018-2023 (USD Billion)
- Spain Nuclear Medicine Diagnostics Market By Type, From 2018-2023 (USD Billion)
- Spain Nuclear Medicine Diagnostics Market By Application, From 2018-2023 (USD Billion)
- Germany Nuclear Medicine Diagnostics Market By Type, From 2018-2023 (USD Billion)
- Germany Nuclear Medicine Diagnostics Market By Application, From 2018-2023 (USD Billion)
- Italy Nuclear Medicine Diagnostics Market By Type, From 2018-2023 (USD Billion)
- Italy Nuclear Medicine Diagnostics Market By Application, From 2018-2023 (USD Billion)
- France Nuclear Medicine Diagnostics Market By Type, From 2018-2023 (USD Billion)
- France Nuclear Medicine Diagnostics Market By Application, From 2018-2023 (USD Billion)
- U.K SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
- Spain SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
- Germany SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
- Italy SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
- France SPECT Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
- U.K PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
- Spain PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
- Germany PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
- Italy PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
- France PET Diagnostic Radioisotopes Market By Type, From 2018-2023 ( USD Billion )
Licence Type 
Clients
Why buy reports from Market Data Forecast
Free Customization
Free report customization that helps you gain required information for always being one step ahead of the competition
Post Purchase Support
6 months of post purchase support via email and phone; serving your needs 24x7 and helping you troubleshoot any technical issues
Best Price guaranteed
Customer focused research services and expertly devised strategic analyses made into premium quality reports at lowest prices
Insightful Snapshots
Summarized overviews of entire reports into customized presentations to ascertain market estimations and driving forces at a quick glance